Lacryvisc

Carbomer 974p, the active ingredient in Lacryvisc, is a excipient presented as a ophthalmic solution for ocular use. It provides viscosity enhancement and ocular surface lubrication. GNH USA supplies Lacryvisc as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals and clinics worldwide.

Lacryvisc is used as an ocular lubricant that addresses dry eye and supports post‑operative eye care.

Dry eye syndrome: provides sustained lubrication to relieve discomfort and visual disturbance. Post‑operative eye care: helps maintain moisture and comfort after ocular surgery. Contact lens wear: offers temporary relief of lens‑related dryness when recommended by an eye care professional.

Lacryvisc may cause ocular reactions, ranging from mild irritation to rare serious events.

Common Side Effects: - Transient stinging or burning sensation upon instillation - Temporary blurred vision - Mild conjunctival redness

Serious or Rare Side Effects: - Allergic conjunctivitis with swelling - Corneal epithelial defect - Persistent eye pain or vision loss

When using Lacryvisc, consider the following safety measures.

Allergy screening: verify patient has no known hypersensitivity to Carbomer 974p or formulation components. Infection control: avoid use in eyes with active bacterial or viral infection unless directed. Contact lens use: remove lenses before instillation and re‑insert after the drop has been absorbed. Pregnancy and lactation: use only if benefit outweighs potential risk, under professional advice. Eye surgery: follow surgeon’s postoperative regimen; do not substitute without guidance. Store at room temperature: keep in original container, protect from moisture and direct light.

Lacryvisc may interact with other ophthalmic products; monitor patients accordingly.

Major Interactions (Avoid): - Concurrent use with ophthalmic solutions containing preservatives that may increase irritation. - Use with anti‑inflammatory eye drops that could alter viscosity and drug distribution. - Combination with ocular antibiotics that require a clear visual field may be compromised.

Moderate Interactions (Monitor Closely): - Simultaneous administration with other lubricating drops may affect overall tear film stability. - Use with contact lens solutions may cause temporary lens discomfort. - Co‑administration with intra‑ocular pressure‑lowering agents should be monitored for any change in drug absorption.